125 related articles for article (PubMed ID: 3999235)
41. The effect of a thromboxane receptor antagonist on acute ePTFE arterial graft thrombogenicity--an experimental study in sheep.
Lundell A; Bergqvist D; Leide S; Lindblad B; Ljungberg J
Eur J Vasc Surg; 1991 Jun; 5(3):321-6. PubMed ID: 1830856
[TBL] [Abstract][Full Text] [Related]
42. Preincubation of Dacron grafts with recombinant tissue factor pathway inhibitor decreases their thrombogenicity in vivo.
Rubin BG; Toursarkissian B; Petrinec D; Yang LY; Eisenberg PR; Abendschein DR
J Vasc Surg; 1996 Nov; 24(5):865-70. PubMed ID: 8918335
[TBL] [Abstract][Full Text] [Related]
43. Current arterial prostheses. Experimental evaluation by implantation in the carotid and circumflex coronary arteries of the dog.
Sauvage LR; Walker MW; Berger K; Robel SB; Lischko MM; Yates SG; Logan GA
Arch Surg; 1979 Jun; 114(6):687-91. PubMed ID: 156533
[TBL] [Abstract][Full Text] [Related]
44. The effect of inhibition of thromboxane synthesis in experimental thrombosis and hemostasis.
Bergqvist D; Björck CG; Dougan P; Esquivel CO; Lannerstad O; Nilsson B; Saldeen P; Saldeen T
Thromb Res; 1985 Feb; 37(3):435-48. PubMed ID: 3838828
[TBL] [Abstract][Full Text] [Related]
45. Nonthrombogenic small-caliber human umbilical vein vascular prosthesis.
Venkataramani ES; Senatore F; Feola M; Tran RM
Surgery; 1986 Jun; 99(6):735-43. PubMed ID: 3086995
[TBL] [Abstract][Full Text] [Related]
46. Fibrin glue containing fibroblast growth factor type 1 and heparin decreases platelet deposition.
Zarge JI; Husak V; Huang P; Greisler HP
Am J Surg; 1997 Aug; 174(2):188-92. PubMed ID: 9293842
[TBL] [Abstract][Full Text] [Related]
47. Acute thrombogenicity of collagen coating of dacron grafts: an experimental study in sheep.
Konrad P; Dougan P; Bergqvist D
Eur J Vasc Surg; 1992 Jan; 6(1):67-72. PubMed ID: 1532559
[TBL] [Abstract][Full Text] [Related]
48. Hydrophilic polyurethane versus autologous femoral vein as substitutes in the femoral arteries of dogs: quantification of platelets and fibrin deposits.
Teijeira FJ; Lamoureux G; Tétreault JP; Bauset R; Guidoin R; Marois Y; Paynter R; Assayed F
Biomaterials; 1989 Mar; 10(2):80-4. PubMed ID: 2706305
[TBL] [Abstract][Full Text] [Related]
49. The ex-vivo-shunt-model: novel approach for assessing the thrombogenicity of vascular implants.
Wilhelmi MH; Gratz KF; Mischke R; von Depka M; Noske D; Francis T; Haverich A; Mertsching H
Int J Artif Organs; 2003 Dec; 26(12):1095-103. PubMed ID: 14738193
[TBL] [Abstract][Full Text] [Related]
50. Comparison of platelet adherence and aggregation in modified human umbilical vein and autogenous vein grafts.
Roedersheimer LR; Feins RH; Schwartz SI; DeWeese JA; Green RM
Am J Surg; 1980 Nov; 140(5):591-5. PubMed ID: 7435812
[TBL] [Abstract][Full Text] [Related]
51. Effects of different graft preparation techniques on the acute thrombogenicity of autologous vein grafts. An experimental study in sheep.
Lannerstad O; Dougan P; Bergqvist D
Eur Surg Res; 1987; 19(6):395-9. PubMed ID: 3446498
[TBL] [Abstract][Full Text] [Related]
52. PPS-PEG surface coating to reduce thrombogenicity of small diameter ePTFE vascular grafts.
Karrer L; Duwe J; Zisch AH; Khabiri E; Cikirikcioglu M; Napoli A; Goessl A; Schaffner T; Hess OM; Carrel T; Kalangos A; Hubbell JA; Walpoth BH
Int J Artif Organs; 2005 Oct; 28(10):993-1002. PubMed ID: 16288437
[TBL] [Abstract][Full Text] [Related]
53. The fate of human umbilical vein grafts as an infrarenal aortic substitute in monkeys.
Guidoin R; Noël HP; Dubé S; de Estable-Puig RF; Marois M; King M
J Vasc Surg; 1985 Sep; 2(5):715-23. PubMed ID: 4032610
[TBL] [Abstract][Full Text] [Related]
54. [Value of carbon in the thrombogenicity of cardiovascular prostheses].
Babatasi G; Bara L; Massetti M; Galateau F; Bloch MF; Boulakia-Cohen F; Khayat A; Samama MM
Ann Cardiol Angeiol (Paris); 1997 Jan; 46(1):7-14. PubMed ID: 9092377
[TBL] [Abstract][Full Text] [Related]
55. The uptake of platelets, fibrinogen and leucocytes in ePTFE vascular grafts in relation to blood flow--an experimental study in sheep.
Lundell A; Bergqvist D; Lindblad B
Eur J Vasc Surg; 1993 Nov; 7(6):698-703. PubMed ID: 8270074
[TBL] [Abstract][Full Text] [Related]
56. [Comparative analysis of the biomechanical properties of human umbilical vein grafts and of the main major arteries].
Pokrovskiĭ AV; Purinia BA; Kazanchian PO; Mungalov DD; Buianovskiĭ VL
Klin Khir (1962); 1981 Jul; (7):15-7. PubMed ID: 7277980
[No Abstract] [Full Text] [Related]
57. The role of heparin binding surfaces in the direction of endothelial and smooth muscle cell fate and re-endothelialization.
Yang Z; Tu Q; Wang J; Huang N
Biomaterials; 2012 Oct; 33(28):6615-25. PubMed ID: 22784604
[TBL] [Abstract][Full Text] [Related]
58. Aneurysm formation in modified human umbilical vein grafts.
Strobel R; Boontje AH; Van Den Dungen JJ
Eur J Vasc Endovasc Surg; 1996 May; 11(4):417-20. PubMed ID: 8846174
[TBL] [Abstract][Full Text] [Related]
59. Mural degeneration in the glutaraldehyde-tanned umbilical vein graft: incidence and implications.
Hasson JE; Newton WD; Waltman AC; Fallon JT; Brewster DC; Darling RC; Abbott WM
J Vasc Surg; 1986 Sep; 4(3):243-50. PubMed ID: 3091855
[TBL] [Abstract][Full Text] [Related]
60. An animal model for the evaluation of graft thrombosis in the acute phase on carbon-lined PTFE prosthesis.
Babatasi G; Bara L; Galateau F; Agostini D; Massetti M; Gerard JL; Rossi A; Bloch MF; Samama MM; Khayat A
Int J Artif Organs; 1994 Dec; 17(12):643-50. PubMed ID: 7759144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
